Enjoy 20% off your first order · use code Free shipping on orders $100+ · free 2-Day $175+Ships today when you order before 3 PM ET

Compound ProfilesNovember 10, 202612 min readCodex Research Team

What Is GHK-Cu? The Copper Peptide in Lab Research

Explore products
CR
Codex Research TeamPublished November 10, 2026

12 min read14 cited sources15 FAQs

Model of three blue glass spheres holding a copper-coloured sphere at the centre, representing GHK-Cu
GHK-Cu in one picture: three amino acids (blue) holding a single copper ion (centre). Remove the copper and several of its reported effects in cell culture disappear.

GHK-Cu is three amino acids wrapped around a copper ion, and that copper is the reason the powder is blue. This profile covers what the molecule is, how tightly it holds its metal, what fifty years of cell-culture research report, where the evidence is thin, and what a certificate for a copper peptide should show.

Key takeaways

  • GHK is the tripeptide glycyl-L-histidyl-L-lysine, about 340 Da. Bound to one copper(II) ion it becomes GHK-Cu, about 402 Da. It was first isolated from human plasma in 1973.
  • GHK holds copper through three nitrogen atoms with a dissociation constant near 7 × 10⁻¹⁴ M, tight enough to compete with albumin for copper in laboratory tests.
  • In fibroblast culture, GHK-Cu is reported to raise collagen and glycosaminoglycan synthesis and to change MMP-2 and TIMP levels. Several effects peak near nanomolar concentrations and fade at higher ones.
  • The copper matters. In one study copper ions reproduced the MMP-2 effect and the peptide alone did not, so experiments need copper-only and peptide-only controls.
  • GHK-Cu is small, polar and metal-bound, which makes it harder to test than most peptides. It is not approved by the FDA as a drug.
Important

Research use only. This profile describes the structure of a research peptide and how it is studied in laboratory models. It does not describe human or animal use. Codex Research compounds are not approved by the FDA and are sold for in-vitro laboratory research only.

Quick answer

GHK-Cu is a three-amino-acid peptide holding one copper ion. The peptide is glycyl-L-histidyl-L-lysine, written GHK, and weighs about 340 Da. With a copper(II) ion attached it weighs about 402 Da and turns blue. Loren Pickart isolated the peptide from human plasma in 1973 [1].

Labs study GHK-Cu mainly in collagen and extracellular-matrix models. In cultured fibroblasts it is reported to raise collagen and glycosaminoglycan synthesis and to change the enzymes that remodel the matrix [3, 4, 5]. The evidence comes largely from cell culture and from a small number of research groups. The FDA has not approved GHK-Cu as a drug [14].

GHK-Cu at a glance

Property GHK-Cu
Peptide sequence Gly-His-Lys (GHK)
Metal One copper(II) ion per peptide
Molecular formula (peptide) C14H24N6O4
Molecular weight About 340.4 Da (GHK); about 401.9 Da (copper complex)
CAS numbers 49557-75-7 (GHK); 89030-95-5 (GHK-Cu)
Appearance Blue powder; the free peptide is white
Other names Copper Tripeptide-1 (cosmetic labels), copper-GHK, prezatide copper
First described 1973, isolated from human plasma [1]
Main research area Collagen, glycosaminoglycans and matrix remodelling
Current Codex lot FLL-0629, 99.78% by HPLC

Where GHK-Cu comes from

Pickart was studying a factor in human serum that prolonged the survival of cultured liver cells. He identified it as the tripeptide glycyl-L-histidyl-L-lysine [1]. Seven years later his group reported that the peptide binds copper readily and increases copper uptake into cultured cells, and proposed that it works as a copper carrier [2]. That proposal still frames most of the research, which looks at the peptide as a way of moving copper to the cells that need it.

A second observation gave the peptide a possible source inside tissue. The same three-residue sequence sits in the alpha 2 chain of type I collagen. A French group suggested that proteases could release it wherever collagen is broken down, which would make GHK a signal generated by the matrix itself [3].

Pickart's later reviews report that plasma GHK is about 200 ng/mL at age 20 and about 80 ng/mL by age 60 [9]. Those figures come from his own measurements and are widely repeated. Read them as one group's data.

How GHK holds copper

The copper is the centre of the molecule's chemistry, and it has been mapped in detail.

  • Three nitrogens grip the metal. In solution, copper(II) binds the amino group of glycine, the nitrogen of the first peptide bond and a nitrogen in the histidine ring. A fourth, loosely held position is open to other molecules, and free amino acids such as histidine or glycine can occupy it to form mixed complexes [10, 11].
  • The grip is tight. Calorimetry measured a dissociation constant of about 7 × 10⁻¹⁴ M at pH 7.4, with one copper per peptide [12].
  • It can compete with albumin. Albumin carries much of the exchangeable copper in plasma. In an equilibrium-dialysis experiment with equal concentrations of the two, about 42% of the copper was found on the peptide [10].
  • Copper moves on and off quickly. Unlike some other copper-binding peptides, GHK exchanges its copper fast, which is consistent with the carrier role proposed for it in 1980 [2, 11].

Copper binding depends on pH. The nitrogens that hold the metal pick up protons in acid, so acidic conditions favour release of the copper. That has a practical consequence for testing, covered below.

GHK and GHK-Cu are different reagents

Papers and labels use the two names loosely. They describe different things: the free peptide and the copper complex. One fibroblast study makes the distinction concrete. GHK-Cu raised MMP-2 levels, copper ions alone reproduced the effect, and the peptide without copper did not [5]. An experiment that reports a "GHK" result without saying which form was used leaves out the variable that may explain it.

How GHK-Cu is studied in the lab

Most of the foundational work uses human dermal fibroblasts, the cells that build and maintain connective tissue.

Research line Model system Reported finding Source
Collagen synthesis Fibroblast culture Increase beginning near 10⁻¹² M and peaking at 10⁻⁹ M, with no change in cell number [3]
Glycosaminoglycans Human fibroblasts More dermatan sulfate and heparan sulfate; no change in hyaluronic acid [4]
Matrix remodelling Dermal fibroblasts Higher MMP-2 protein and mRNA; more TIMP-1 and TIMP-2 secreted [5]
Keratinocytes Monolayers and skin-equivalent models More proliferation; higher integrin alpha 6 and beta 1, PCNA and p63 [6]
Growth factors Normal and irradiated fibroblasts Faster doubling; early rise in bFGF and VEGF from irradiated cells [7]
Gene expression Public cell-line dataset Expression changes across a large share of human genes [8]

Collagen and glycosaminoglycans

The 1988 collagen study set the pattern for the field. GHK-Cu increased collagen synthesis in fibroblast cultures at picomolar to nanomolar concentrations, and the increase did not come from having more cells [3]. A follow-up from the same laboratory measured glycosaminoglycans, the sugar chains that fill the space between collagen fibres. GHK-Cu preferentially raised dermatan sulfate outside the cell and heparan sulfate on the cell layer, and left hyaluronic acid unchanged [4].

Building and breaking down the matrix

Cells turn the matrix over as well as build it. The 2000 study showed that GHK-Cu also raises MMP-2, an enzyme that degrades matrix proteins, together with TIMP-1 and TIMP-2, the proteins that restrain it [5]. The authors read this as remodelling: production and turnover moving together. The same group had earlier reported more connective-tissue accumulation in a rat dermal model [13].

Keratinocytes and growth factors

Work outside the fibroblast broadened the picture. In skin-equivalent models, copper-GHK made basal keratinocytes more proliferative and raised integrins and p63, a marker associated with the stem-cell population of the epidermis [6]. In serum-free culture, fibroblasts that had been exposed to radiation doubled faster with GHK-Cu and produced more basic fibroblast growth factor and VEGF early on [7].

The response curve bends

Several of these studies share a feature that is easy to miss. The response rises, peaks and then falls. Glycosaminoglycan synthesis peaked between 10⁻⁹ and 10⁻⁸ M and drifted back toward control at higher concentrations [4]. Collagen synthesis peaked at 10⁻⁹ M [3]. A single high concentration can therefore miss the effect entirely, which is why this compound needs a concentration series.

The gene-expression data

The most quoted modern claim about GHK comes from a computational analysis. Using the Broad Institute's Connectivity Map, a public library of gene-expression responses in cultured cell lines, Pickart and Margolina reported that GHK changed the expression of about 31% of human genes by 50% or more [8].

Read that figure with its limits in view. It describes cell lines exposed to the compound in a screening dataset. One group produced the analysis. A change in a gene's transcript does not show a change in protein or in cell behaviour. The dataset is useful for generating hypotheses and each hypothesis still needs its own experiment.

How strong is the evidence?

GHK-Cu has a longer research record than most peptides sold for laboratory use, and the record has clear limits.

  1. Two groups produced much of the classic work. Pickart's laboratory and the Reims group led by Maquart account for many of the foundational papers [1, 2, 3, 4, 5, 13]. Independent groups have added the keratinocyte, irradiated-fibroblast and copper-chemistry studies [6, 7, 11, 12].
  2. Most findings are from cell culture. Animal work exists, mainly in rodent dermal models [13]. Controlled human trials of the kind that support an approved drug do not.
  3. The chemistry is the strongest part. The structure of the copper complex and its binding strength have been measured by several methods that agree with each other [10, 11, 12].
  4. The mechanism in cells is unsettled. Copper delivery, matrix signalling and gene-expression effects have all been proposed. They may overlap.

Testing a copper peptide

GHK-Cu is harder to analyse than a typical research peptide, for three reasons.

  • It is small and polar. Three residues with several charged groups pass quickly through a standard reversed-phase HPLC column. Labs adjust the method to hold the compound long enough to separate it from impurities.
  • It carries a metal. Peptide purity by HPLC does not measure copper. Copper content needs an elemental method such as ICP.
  • Acid can strip the copper. HPLC and LC-MS commonly use acidic mobile phases. Under those conditions the complex can release its metal, so a mass spectrometer often detects the free peptide near m/z 341 even when the vial holds the copper complex.

What a full GHK-Cu report can include

Line What it answers Typical method
Identity Is the peptide GHK? LC-MS; the free peptide appears near m/z 341, with a doubly charged ion near m/z 171
Purity How much of the peptide material is GHK? HPLC with a method suited to small polar compounds
Copper content Is the metal present in the expected amount? ICP-OES or ICP-MS
Counter-ion and water How much of the powder is neither peptide nor copper? Ion chromatography; Karl Fischer titration
Endotoxin Is bacterial contamination below the stated limit? LAL

Copper content gives a useful cross-check. One copper atom in a complex of about 401.9 Da is about 15.8% of the mass. A salt form or residual water lowers the measured figure, so a result somewhat under that value is expected, and a result near zero points to the free peptide.

The current Codex lot

The current Codex lot, FLL-0629, was tested by Accurate Test Labs and reported on July 14, 2026:

Test Specification Method Result
Purity Report HPLC (TM-13) 99.784%
Endotoxin ≤ 7.00 EU/mg LAL 0.10 EU/mg

This report covers purity and endotoxin. It does not carry a separate identity line, so request one from info@codexresearch.shop if your work depends on it. The endotoxin result is given as a number, which is more useful than a bare "pass". What endotoxin testing means explains how to read it, and HPLC vs mass spec covers why purity and identity need different instruments.

A simple visual check also applies to this compound. GHK-Cu powder is blue. A white powder in a vial labelled GHK-Cu suggests the free peptide. Whatever a certificate lists, the issuing laboratory can confirm whether it is real. Our guide to third-party testing gives the steps.

Stability and storage as a research material

Codex supplies GHK-Cu freeze-dried. The powder is hygroscopic and takes up water from humid air, so a sealed vial belongs somewhere cold, dry and dark, with its lot number recorded beside it.

Two points are specific to a copper complex. Acidic conditions favour release of the metal, as described above. And copper(II) in this complex is stable under moderate conditions but can be reduced to copper(I) at strongly reducing potentials, which releases the ion [11]. Strong reducing agents in an assay buffer are therefore worth noting in the study record.

For the journey from our facility to yours, see research peptides in transit.

Planning in-vitro work with GHK-Cu

Five habits separate a clean GHK-Cu experiment from an ambiguous one.

  1. Run three arms. GHK-Cu, the peptide without copper, and a copper salt at the matching concentration. Without them an effect cannot be assigned to the complex [5].
  2. Use a concentration series. The classic effects peak near nanomolar levels and decline above them [3, 4]. Span several orders of magnitude.
  3. Work in molar units. One milligram of GHK-Cu is about 2.5 micromoles, more than three times the number of molecules in a milligram of BPC-157.
  4. Mind the serum. Albumin binds copper and competes with GHK for it [10]. Serum-free and serum-containing media can give different results, and one of the growth-factor studies was run serum-free [7].
  5. Stay on one lot and write it down. The lot number, the purity and the form supplied (complex or free peptide, and which salt) all belong in the methods.

GHK-Cu beside BPC-157 as a research material

The two best-known compounds in this catalogue ask different things of a lab.

GHK-Cu BPC-157
Size 3 amino acids plus copper, about 402 Da 15 amino acids, about 1,419.5 Da
Metal Copper(II), part of the molecule None
Main research area Collagen, glycosaminoglycans, matrix remodelling Endothelial and fibroblast signalling
Typical cells Dermal fibroblasts, keratinocytes Endothelial cells, tendon fibroblasts
Controls that matter most Peptide without copper; copper salt alone Positive growth-factor control; lot record
Hardest part of testing Small, polar, and copper is measured separately No aromatic residues, so detection relies on the peptide bond
Shape of the evidence Fifty years of cell culture, strong chemistry Wide preclinical base, no confirmed receptor

Our BPC-157 profile covers the right-hand column in full.

Regulatory status

GHK-Cu has no FDA approval as a drug. Codex Research supplies it for in-vitro laboratory work, on the terms set out in what research use only means.

Two other facts are often confused with approval:

  • Cosmetics. The complex appears on cosmetic labels as Copper Tripeptide-1. Cosmetic ingredients are regulated differently from drugs and from research compounds.
  • Compounding. In September 2023 the FDA placed an entry for GHK-Cu in Category 2 of its interim compounding list, citing possible immunogenicity from aggregation and peptide-related impurities. In April 2026 it removed that entry after the nominations were withdrawn [14]. Neither step is an approval. This section reflects the position in November 2026.

Common misconceptions

"GHK and GHK-Cu are interchangeable." They are the peptide and its copper complex. In at least one study the copper, not the peptide, carried the effect [5].

"More is better." Several reported effects peak near nanomolar concentrations and fade above them.

"It changes a third of the genome, so it does everything." The figure comes from a screening dataset in cell lines. It lists transcripts that moved and says nothing about what a cell or tissue does as a result.

"A purity result proves the copper is there." HPLC purity describes the peptide. Copper needs its own measurement.

"It is approved because it is in skin-care products." A cosmetic ingredient listing is not a drug approval.

AHK-Cu is a close relative in which alanine replaces glycine. It is a separate compound with a much smaller literature.

Codex Research supplies GHK-Cu on its own and as the largest component of two research blends. Glow combines it with BPC-157 and TB-500, and Klow adds KPV. Glow vs Klow compares the two blends component by component, and What is BPC-157? profiles the peptide they share with GHK-Cu.

What this profile does not tell you

This profile covers structure, copper chemistry, the research literature, testing and regulation. It does not describe how GHK-Cu behaves in any person or animal, establish safety or effectiveness for any purpose, or replace the certificate for the lot you hold. Research compounds are not approved by the FDA for human or veterinary use.

How Codex Research documents GHK-Cu

Each Codex GHK-Cu lot is tested by an independent laboratory, and the report is published on the product page with the laboratory and report number named. Check that the lot printed on your vial is the lot on that page. To request the complete report, or an identity result for a specific lot, write to info@codexresearch.shop.

Frequently asked questions

What is GHK-Cu?
GHK-Cu is a complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK) with one copper(II) ion. The peptide was first isolated from human plasma in 1973, and the complex is used as a research compound, mainly in collagen and extracellular-matrix models.
What does GHK stand for?
G, H and K are the one-letter codes for its three amino acids: glycine, histidine and lysine. Cu is the chemical symbol for copper.
What is the difference between GHK and GHK-Cu?
GHK is the peptide on its own, about 340 Da. GHK-Cu is the same peptide holding a copper(II) ion, about 402 Da. They can behave differently in cell culture, so a study should state which form it used.
Why is GHK-Cu blue?
The colour comes from the copper(II) ion. When three nitrogen atoms of the peptide bind the metal, the complex absorbs orange-red light and appears blue. The peptide without copper is white.
What is the molecular weight of GHK-Cu?
About 340.4 Da for the GHK peptide (C14H24N6O4) and about 401.9 Da for the 1:1 copper complex. Salt forms such as the acetate weigh more because of the counter-ion.
How strongly does GHK bind copper?
Strongly, for a three-residue peptide. Calorimetry measured a dissociation constant of about 7 × 10⁻¹⁴ M at pH 7.4. In an equilibrium test with equal amounts of GHK and albumin, about 42% of the copper sat on the peptide.
Where does GHK occur naturally?
It was isolated from human plasma, and the same three-residue sequence occurs inside the alpha 2 chain of type I collagen. Researchers have proposed that proteases release it when collagen is broken down.
What is GHK-Cu studied for in the lab?
Mostly the extracellular matrix. Cell-culture studies report effects on collagen synthesis, glycosaminoglycan synthesis, MMP-2 and its inhibitors in fibroblasts, and on integrins and p63 in keratinocyte models.
Does the copper matter, or is it the peptide?
It depends on the effect. In one fibroblast study copper ions alone reproduced the rise in MMP-2 and the peptide alone did not. That is why well-designed experiments include copper-only and peptide-only controls.
Is more GHK-Cu always more effective in a cell assay?
No. Several classic studies found a peak near nanomolar concentrations. Glycosaminoglycan synthesis, for example, peaked between 10⁻⁹ and 10⁻⁸ M and returned toward control levels at higher concentrations.
Is GHK-Cu FDA approved?
No. The FDA has not approved GHK-Cu as a drug. Codex Research sells it for in-vitro laboratory research only.
Is GHK-Cu the same as copper tripeptide-1?
Copper Tripeptide-1 is the ingredient name used on cosmetic labels for the GHK copper complex. Cosmetic ingredients and research compounds are regulated as different categories even when the molecule is the same.
How is GHK-Cu tested?
Purity is measured by HPLC, although small polar peptides are harder to separate than larger ones. Identity is confirmed by mass spectrometry, where the free peptide appears near m/z 341. Copper content can be measured separately by an elemental method such as ICP.
How is GHK-Cu different from AHK-Cu?
AHK-Cu replaces the first amino acid, glycine, with alanine. The two are separate compounds with separate certificates, and far fewer published studies cover AHK-Cu.
How should GHK-Cu be stored as a research material?
It is supplied as a lyophilized powder. Sealed vials are kept cold, dry and away from light, and the lot number stays with the vial so it can be matched to its certificate.

References

  1. Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85-87.
  2. Pickart L, Freedman JH, Loker WJ, et al. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. 1980;288(5792):715-717.
  3. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-346.
  4. Wegrowski Y, Maquart FX, Borel JP. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Life Sci. 1992;51(13):1049-1056.
  5. Siméon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67(18):2257-2265.
  6. Kang YA, Choi HR, Na JI, et al. Copper-GHK increases integrin expression and p63 positivity by keratinocytes. Arch Dermatol Res. 2009;301(4):301-306.
  7. Pollard JD, Quan S, Kang T, Koch RJ. Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. Arch Facial Plast Surg. 2005;7(1):27-31.
  8. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.
  9. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108.
  10. Lau SJ, Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochem J. 1981;199(3):649-656.
  11. Hureau C, Eury H, Guillot R, et al. X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. Chemistry. 2011;17(36):10151-10160.
  12. Trapaidze A, Hureau C, Bal W, Winterhalter M, Faller P. Thermodynamic study of Cu2+ binding to the DAHK and GHK peptides by isothermal titration calorimetry (ITC) with the weaker competitor glycine. J Biol Inorg Chem. 2012;17(1):37-47.
  13. Maquart FX, Bellon G, Chaqour B, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest. 1993;92(5):2368-2376.
  14. U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks.
For research use only. This article summarizes published laboratory and preclinical literature for reference. It is not medical advice. Codex Research products are not FDA approved and are not for human or animal consumption or for any clinical or medical use.

Shop the lab

Popular research peptides

BPC-157Repair

Research peptide

BPC-157

Tissue-Repair Research

BPC-157 is a 15-amino-acid synthetic peptide taken from a gastric-juice protein, studied in endothelial, fibroblast and growth-factor research. Lot-tested by HPLC and LC-MS.

99%+Purity+149Reward pts
$59.99
View product
TB-500Repair

Research peptide

TB-500

Tissue-Repair Research

TB-500 is Ac-LKKTETQ, the acetylated actin-binding fragment of Thymosin Beta-4 (residues 17–23), supplied as a lyophilized peptide for actin-regulation and cell-migration research.

99%+Purity+187Reward pts
$74.99
View product
GHK-CuDermal

Research peptide

GHK-Cu

Dermal Matrix Research

GHK-Cu is the copper(II) complex of the tripeptide Gly-His-Lys, a constituent of human plasma, studied in fibroblast matrix and copper-transport research. Lot-tested by HPLC.

99%+Purity+99Reward pts
$39.99
View product
GlowBlends

Research peptide

Glow

Repair Blend

Glow is a three-peptide research blend: 49.87 mg GHK-Cu, 9.88 mg BPC-157 and 9.32 mg TB-500 per vial on the current lot, measured by HPLC and tested on a full safety panel.

99%+Purity+237Reward pts
$94.99
View product
NAD+Cellular

Research peptide

NAD+

Cellular Research

NAD+ is nicotinamide adenine dinucleotide, the oxidized redox coenzyme and sirtuin substrate, supplied as lyophilized powder in 500 mg and 1000 mg vials. Lot-tested by LC-MS.

99%+Purity+224Reward pts
$89.99
View product
KlowBlends

Research peptide

Klow

Repair Blend

Klow is a four-peptide research blend: 51.33 mg GHK-Cu, 11.55 mg KPV, 9.32 mg TB-500 and 8.00 mg BPC-157 per vial on the current lot, for multi-pathway laboratory research.

99%+Purity+249Reward pts
$99.99
View product
Melanotan IIDermal

Research peptide

Melanotan II

Melanocortin Research

Melanotan II is a cyclic lactam analog of alpha-MSH that binds the melanocortin receptors, lot-tested at 99.91% purity with a published certificate.

99%+Purity+112Reward pts
$44.99
View product
IpamorelinGH axis

Research peptide

Ipamorelin

GH-Axis Research

Ipamorelin is a five-residue synthetic peptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, studied as a selective agonist at the ghrelin receptor. Lot-tested by RP-HPLC.

99%+Purity+87Reward pts
$34.99
View product
SemaxNeuro

Research peptide

Semax

Neuropeptide Research

Semax is a seven-residue ACTH(4-7) analogue with a Pro-Gly-Pro tail, studied in BDNF, trkB and cholinergic-neuron research. 5 mg and 10 mg vials, lot-tested by LC-MS.

99%+Purity+124Reward pts
$49.99
View product
SelankNeuro

Research peptide

Selank

Neuropeptide Research

Selank is a seven-residue tuftsin analogue, Thr-Lys-Pro-Arg-Pro-Gly-Pro, studied in enkephalinase and neurotransmission gene-expression research. Lot-tested by LC-MS.

99%+Purity+112Reward pts
$44.99
View product

Keep reading

Compound Profiles
November 10, 2026

What Is BPC-157? Structure, Research and Testing

BPC-157 is one of the most searched research peptides in the United States and one of the least understood. This profile covers what the molecule is, where its name comes from, which signalling pathways it is studied in, how much of the evidence holds up, and how to read the certificate for a specific lot.

Read Article
Compound Profiles
November 9, 2026

Glow vs Klow: How the Two Research Peptide Blends Differ

Glow and Klow share three of their peptides. The difference is one small molecule, KPV, and everything that follows from adding it: a fourth research pathway, a higher total mass and a harder job for the testing lab. This guide compares the two blends component by component.

Read Article
Purity & COAs
November 14, 2026

What a Peptide Certificate of Analysis Can't Tell You

A certificate of analysis reports the tests a lab ran on one sample on one date. This guide sets out eight things the page cannot tell you, from untested properties and method blind spots to storage after the test, and names the document that fills each gap.

Read Article

From lab to your door

Every compound.Every lot, proven.

U.S.-made research vials, shipped with lot-matched, lab-tested COAs you can scan straight off the label.